Attention:
|
Mindy Hooker
Andrew Blume
Evan Ewing
Jay Ingram
|
Re:
|
Carbon Revolution Ltd.
Registration Statement on Form F-4
Filed February 27, 2023
File No. 333-270047
|
1. |
We note your disclosure that you obtained some of the market and industry data included in the registration statement from various third-party sources and that you have not independently verified this
information. This statement appears to imply a disclaimer of responsibility for this information in the registration statement. Please either revise this section to remove such implication or specifically state that you are liable for all
information in the registration statement.
|
2. |
It appears that the Cash and Investment Held in the Trust Account amount in the maximum redemption table does not reflect the impact of 100% of the Twin Ridge Class A ordinary shares being redeemed in connection
with the business combination. Please clarify or update.
|
3. |
Please revise to briefly discuss the reasons that trading of shares of Carbon Revolution was temporarily suspended on October 31, 2022 and also provide the current share price on ASX. Additionally, revise to
state that shares of Carbon Revolution will cease to be quoted on the ASX after the closing of the business combination.
|
4. |
We note the disclosure that the personal and financial interests of the Sponsor as well as Twin Ridge’s executive officers and directors may have influenced their motivation in identifying and selecting Carbon
Revolution as a business combination target. Please revise to discuss how the board considered those conflicts in negotiating and recommending the business combination.
|
5. |
We note that there has been a previous instance of unauthorized access of Carbon Revolution’s IT systems and that when the issue was identified, access was terminated and steps were then taken to increase
security. Please expand your disclosure to discuss the magnitude of the incident, its consequences and, if material, any impact to Carbon Revolution's financial condition. Additionally, please describe the extent and nature of the role of the
board of directors in overseeing cybersecurity risks, including in connection with the Company’s supply chain/suppliers/service providers.
|
6. |
We note that you intend that the merger will qualify as a "reorganization" within the meaning of Section 368(a). Please revise your disclosures to more clearly state counsel's tax opinion on whether the
transaction will qualify as a reorganization. Also, state in your disclosure that the discussion is the opinion of tax counsel and identify counsel. Whenever there is significant doubt about the tax consequences of the transaction, it is
permissible for the tax opinion to use “should” rather than “will,” but counsel providing the opinion must explain why it cannot give a “will” opinion and describe the degree of uncertainty in the opinion. Refer to Sections III.B and C of
Staff Legal Bulletin 19.
|
7. |
We note that financial projections without assumptions were presented to Twin Ridge on October 24, 2022 and revised projections with assumptions were presented to Twin Ridge and Craig-Hallum on November 13,
2022. Please tell us whether the October 24, 2022 projections are materially the same as the projections included in the registration statement. If the projections are materially different, please explain these differences, what changes were
made and why. Additionally, disclose any discussions relating to the assumptions underlying any projections.
|
8. |
Please expand your disclosure to discuss the material assumptions underlying your estimated backlog, quantifying where applicable. Additionally, please revise to disclose the number of years remaining in the
lifetime of the programs included in the estimated backlog and the basis for, and risk related to, including backlog for years beyond CY2024.
|
9. |
We note your disclosure on page 178 that MergeCo intends to grant equity incentive awards equal to 5% of the number of issued and outstanding MergeCo ordinary shares immediately after the closing of the business
combination. Please prominently disclose, if true, that the pro forma financial statements have not been adjusted to reflect such issuance. To the extent the compensation charge is expected to be material, please disclose as such and, if
quantifiable, disclose the expected amount or range of the compensation charge.
|
10. |
Please disclose on the face of the pro forma balance sheet the pro forma common stock issued and outstanding.
|
11. |
We note you "arithmetically derived" Twin Ridge's income statement for the year ended June 30, 2022 from other financial statements. Please clearly disclose your methodology for deriving the related
statement of operations. Also disclose the exchange rate(s) used in translating the Twin Ridge financial statements to Australian dollars.
|
12. |
Regarding pro forma adjustment (b), please explain to us in greater detail and revise your disclosures to clarify what this adjustment represents and why it is necessary. In doing so, explain how you
determined the $34.6 million fair value of the Founder Shares and tell us why your pro forma statement of operations does not appear to reflect an adjustment for the corresponding compensation charge. Additionally, quantify the
fair value of the shares transferred to the directors and explain your consideration of whether a pro forma compensation charge is necessary given the assumed consummation of the recapitalization for pro forma purposes.
|
- |
In the first quarter of 2021, the Sponsor was awarded Twin Ridge Class B Ordinary Shares which automatically convert to Twin Ridge Class A Ordinary Shares on consummation of the Business Combination, pursuant to terms agreed in connection
with Twin Ridge’s initial public offering.
|
- |
The Company then considered whether the issuance of these shares should be considered under IFRS 2 Share-based Payments (IFRS 2) or IAS 32 Financial Instruments: Presentation (IAS 32). In making this assessment, the Company considered
whether the shares were issued to the holders in their capacity as investors, whether they were issued at fair value and the commercial rationale for the issuance of the securities. The Company determined that the issuance of these shares
should be accounted for using an IFRS 2 model for the following reasons: (i) the shares were issued for nominal consideration, (ii) Twin Ridge had previously determined the shares to have a fair value of $5.01, and (iii) the role of the
Founders in the formation of Twin Ridge in the absence of employees acting in the capacity of management. This is in contrast to the accounting under US GAAP where the expense is recognized only when the service condition is probable of
occurrence (i.e., when a special purpose acquisition company consummates a business combination).
|
- |
IFRS2.13A requires that, where identified consideration received is less than the fair value of equity instruments issued, that this typically indicates that other unidentified services have been received by the relevant entity. The
difference between fair value of the shares issued and consideration received, as of grant date, is recognized as a share based compensation charge under IFRS 2.
|
- |
Twin Ridge had determined, through a concurrent award of shares to members of the Twin Ridge Board, that the fair value of Founder Shares was $5.01. Consequently, the Company determined the fair value of the total Founder Share award to be
AUD $34.6M by reference to the $5.01 fair value per share in such award converted at the AUD/USD exchange rates on the relevant grant date, multiplied by the number of shares awarded to the Founders.
|
- |
The Company then assessed the appropriate grant date, specifically, whether any performance conditions or in-substance vesting conditions, such the conversion of any Twin Ridge Class B Ordinary Shares into MergeCo Ordinary Shares, applied
with regard to the timing of recognition of the IFRS 2 charge. In considering this, the Company established that:
|
i. |
the award of Founder Shares in the first quarter of 2021 was not subject to any performance or forfeiture conditions;
|
ii. |
while the Founder Shares could not be redeemed or otherwise converted prior to the consummation of any business combination by Twin Ridge, they did have some fair value; and
|
iii. |
as evidenced by the use of the Founder Shares as currency for other transactions with members of the Twin Ridge Board and third parties, the benefits of the shares had transferred to the Founders at initial grant.
|
13. |
We note that pro forma adjustment 1A impacts borrowings and equity in addition to cash and marketable securities. Please revise your footnote to provide a more comprehensive explanation of all items
included in this pro forma adjustment.
|
14. |
Please tell us how you determined the waiver of deferred underwriting fees reflected in pro forma adjustment 1B should be recorded within income on your statement of operations rather than as an
adjustment to equity.
|
15. |
Please revise your description of pro forma adjustment 1C.1 to explain in greater detail the nature and terms of the share based award payment to advisors.
|
16. |
We note that pro forma adjustments 1C, 1D, 1D.1, 1D.2 and 1D.3 reflect estimated direct and incremental transaction costs. Citing authoritative accounting guidance, as applicable, please
tell us and disclose how Twin Ridge and Carbon Revolution account for all transaction costs. Clearly describe any costs reflected as a reduction of equity rather than expensed. Also revise your disclosures to more
fully describe the nature, amounts, and pro forma treatment of transaction costs included under each redemption scenario. Consider providing a tabular presentation.
|
17. |
We note your disclosure on page 176 that a 100% redemption scenario will result in an IFRS 2 charge for the excess of fair value of MergeCo shares issued to Twin Ridge shareholders.
Please revise your pro forma financial statement footnotes to clearly disclose where this charge has been reflected in the pro forma statement of operations. Also revise the footnotes to prominently disclose that
the maximum redemption scenario would result in a negative cash balance.
|
18. |
We note that you quantify revenue forecasts for fiscal years 2023 and 2024 on page 186. Please revise your disclosures to fully comply with Item 10(b) of Regulation S-K. In
particular, we note that Item 10(b)(2) indicates revenues, net income (loss) and earnings (loss) per share usually are presented together in order to avoid any misleading inferences that may arise when the
individual items reflect contradictory trends and that it generally would be misleading to present revenue projections without one of the foregoing measures of income. In addition, confirm that going forward,
pursuant to Item 10(b)(3)(iii), you will make full and prompt disclosure of material facts, both favorable and unfavorable, regarding previously issued projections.
|
19. |
Please revise to elaborate on the Mega-line project. Clearly state the expected timeline for each phase of the Mega-line project, your current production capacity, your
expected production capacity at each phase of the Mega-line project and an estimate of the capital expenditures required to complete each phase of the project.
|
20. |
Please expand your disclosure to include a description of the sources and availability of raw materials, including a description of whether prices of principal raw
materials are volatile. Refer to Item 4.B.4. of Form 20-F.
|
21. |
We note your discussion of projected revenue in this section differs from the revenue projections disclosed on page 170. Please revise to (i) clarify which are the
latest projections, (ii) clarify if the projections relate to the calendar year or your fiscal year, (iii) discuss material differences from the projections provided to Twin Ridge and Craig-Hallum
and (iv) provide the material assumptions underlying the projections and the limitations of those projections.
|
22. |
If applicable, please expand your discussion of interest rates to describe their impact on your financial condition, including your balance sheet. For example,
given rising rates, describe any resulting impacts on your inventory, accounts payable, long-term debt or accrued expense balances. Expand your disclosure to describe how you are funding these
additional costs.
|
23. |
We note that you have experienced supply chain disruptions. Specify whether these challenges have materially impacted your results of operations or capital
resources and quantify, to the extent possible, how your sales, profits, and/or liquidity have been impacted. Revise to discuss known trends or uncertainties resulting from mitigation
efforts undertaken, if any. Explain whether any mitigation efforts introduce new material risks, including those related to product quality, reliability or regulatory approval of products.
|
24. |
If applicable, please expand your disclosure to identify the principal factors contributing to the inflationary pressures the Company has experienced and
clarify the resulting impact to the Company. Please also update your disclosure to identify actions planned or taken, if any, to mitigate inflationary pressures.
|
25. |
We note that your presentation of “working capital” is calculated as receivables plus inventories less payables. Considering your adjusted working
capital measure excludes certain current liabilities, please tell us how your presentation complies with Item 10(e)(1)(ii)(A) of Regulation S-K, which generally prohibits excluding
charges or liabilities that required or will require cash settlement from non-GAAP liquidity measures. Also see the third bullet of Question 102.10(a) of the Compliance and
Disclosure Interpretations on Non-GAAP Financial Measures.
|
26. |
Please clearly disclose how you calculate debtor days and inventory days. To the extent you use average balances, ensure you specify how the
average is determined..
|
27. |
We note that you are pursuing short-term bridge funding and a new debt facility. Please revise to provide an update on the status of the bridge
funding and new debt facility.
|
28. |
We note that you perform impairment testing of fixed assets, intangible assets, and right of use assets at the consolidated entity level.
Please tell us in sufficient detail how your impairment methodology complies with IAS 36 and why the recoverable amount of each asset type cannot be estimated on an
individual basis or at a cash-generating unit below the consolidated level.
|
29. |
We note your disclosure on page 248 that MergeCo's board shall be divided into three classes. Please revise to specify the class and
term of each director and director nominee.
|
30. |
We note that Carbon Revolution Limited financial statements for the half-year ended December 31, 2022 have been provided on its
website. Please include the interim financial statements in your next amendment. See Item 8.A.5 of Form 20-F.
|
31. |
We note that you reflected payments related to the Australian Federal Government's JobKeeper scheme within operating activities
on your statement of cash flows. Please tell us and disclose your accounting policy for classifying government grants on your statement of cash flows and
explain how your accounting treatment complies with IAS 7 and IAS 20.
|
• |
Operating activities are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities.
|
• |
Investing activities are the acquisition and disposal of long-term assets and other investments not included in cash equivalents
|
• |
Financing activities are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.
|
32. |
Please file the following agreements or explain why you are not required to do so:
|
• |
material lease agreements;
|
• |
material debt agreements; and
|
• |
a form of indemnification agreement with MergeCo.
|
33. |
Please provide us with any correspondence between Barclays, Evercore and Twin Ridge relating to the resignations of
Barclays and Evercore, including the November 15, 2022 letters.
|
34. |
Please provide us with Barclays' and Evercore's engagement letters with Twin Ridge. Please disclose any ongoing
obligations of the Company pursuant to the engagement letters that will survive the termination of the engagement, such as indemnification provisions,
rights of first refusal and lockups, and discuss the impacts of those obligations on the Company in the registration statement.
|
35. |
Please disclose whether Barclays or Evercore assisted in the preparation or review of any materials reviewed by
Twin Ridge's board of directors or management and whether Barclays and Evercore have withdrawn their association with those materials and notified
Twin Ridge of such disassociation. For context, include that there are similar circumstances in which a financial institution is named and that
the resignations indicate that Barclays and Evercore are not willing to have the liability associated with such work in this transaction.
|
36. |
Please revise your disclosure to highlight for investors that the withdrawals of Barclays and Evercore indicate
that they do not want to be associated with the disclosure or underlying business analysis related to the transaction. In addition, revise
your disclosure to caution investors that they should not place any reliance on the fact that Barclays and Evercore have been previously
involved with the transaction.
|
37. |
We understand that Barclays and Evercore, representatives of the underwriters in your SPAC IPO, waived the
deferred underwriting commissions that would otherwise be due to them upon the closing of the business combination. Please disclose how
this waiver was obtained, why the waiver was agreed to and clarify Twin Ridge's current relationship with Barclays and Evercore.
|
38. |
Disclose whether Barclays and Evercore provided you with any reasons for the fee waiver. If there was
no dialogue and you did not seek out the reasons why Barclays and Evercore waived deferred fees, despite already completing their
services, please indicate so in your registration statement. Further, revise the risk factor disclosure to explicitly clarify that
Barclays and Evercore performed all of their obligations to obtain the fee and therefore is gratuitously waiving the right to be
compensated.
|
39. |
Please describe what relationship existed between Barclays/Evercore and Twin Ridge after the close
of the IPO, including any financial or merger-related advisory services conducted by Barclays or Evercore. For example, clarify
whether Barclays or Evercore had any role in the identification or evaluation of business combination targets.
|
40. |
Please tell us whether you are aware of any disagreements with Barclays or Evercore regarding
the disclosure in your registration statement. Further, please add risk factor disclosure that clarifies that Barclays and
Evercore were to be compensated, in part, on a deferred basis for their underwriting services in connection with the SPAC IPO
and such services have already been rendered, yet Barclays and Evercore waived such fees and are disclaiming responsibility
for the registration statement. Clarify the unusual nature of such a fee waiver and the impact of it on the evaluation of the
business combination.
|
41. |
Please provide us with a letter from each of Barclays and Evercore stating whether they
agree with the statements made in your prospectus related to their resignation and, if not, stating the respects in which
they do not agree. Please revise your disclosure accordingly to reflect that you have discussed the disclosure with each
of Barclays and Evercore and they either agree or do not agree with the conclusions and the risks associated with such
outcome. If Barclays and Evercore do not respond, please revise your disclosure to indicate you have asked and not
received a response and disclose the risks to investors.
|
42. |
Your charter waived the corporate opportunities doctrine. Please address this potential
conflict of interest and whether it impacted your search for an acquisition target.
|
43. |
Quantify the value of warrants, based on recent trading prices, that may be
retained by redeeming stockholders assuming maximum redemptions and identify any material resulting risks.
|
44. |
Please update the registration statement to reflect the results of your March
6, 2023 extraordinary general meeting. Please include the number of shares that were redeemed and update the
amount remaining in the trust account throughout the registration statement.
|
Sincerely,
|
|
/s/ Jeffrey A. Letalien
|
cc:
|
Jacob Dingle, Carbon Revolution Ltd.
David Nock, Esq., Carbon Revolution Ltd.
Jocelyn Arel, Esq., Goodwin Procter LLP
Alexander Mackinnon, Esq., Herbert Smith Freehills
Connor Manning, Esq., Arthur Cox LLP
Christian Nagler, Esq., Kirkland & Ellis LLP
Peter Seligson, Esq., Kirkland & Ellis LLP
|